| abstract |
It is an object of the present invention to provide a compound that can be satisfied as an oral drug having a therapeutic effect on the basis of chemokine inhibitory action. The present inventors have found that benzyl piperidine derivative (formula (1)) has chemokine inhibitory activity. As a result of intensive studies, the present inventors have succeeded in increasing the chemokine inhibitory activity and blood stability of the compound, and have completed the present invention.n n n n n n n n (Wherein each symbol is defined as described in the specification) |